Day: September 14, 2022

Posted on

Grand Richmond Hotel Achieves GHA’s WellHotel® Accreditation for Medical Travel & Well-being

PALM BEACH GARDENS, Fla., Sept. 14, 2022 /PRNewswire/ — Grand Richmond Hotel, one of Bangkok’s premier hotels was awarded WellHotel® Accreditation for Medical Travel and Well-being by Global Healthcare Accreditation (GHA).

Setting the standard for luxury events and business and leisure stays, the Grand Richmond Hotel is a distinctive five-star convention venue and hotel located in northern Bangkok just a short drive from the city center. The hotel is operated by the Richmond Group, one of Thailand’s premier hoteliers, who recently added a new 35-story tower to the property and upgraded the existing facilities with an elegant remodel and redesign. The hotel welcomes travelers from all over the world and is sought-after a destination for guests seeking to focus on their well-being or recover after a medical treatment.

GHA recently launched WellHotel® Accreditation for hotels seeking to enhance the guest experience and safety protocols for wellness and/or medical travel guests. GHA WellHotel® for Well-being and WellHotel® for Medical Travel focuses on validating the services and programs hotels provide for these growing markets and the accreditation seal builds trust and offers a competitive edge to those hotels that achieve accredited status.

Ms. Laksawan Wongworrakan, Grand Richmond Hotel’s Chief Executive Officer stated, “At Grand Richmond we strive to offer each guest the most exquisite experience with the utmost attention to detail. Many of our guests choose the Grand Richmond Hotel to focus on their health and well-being. We offer them a calm and healing environment with safety protocols and services that meet their unique needs. It is an honor to have achieved GHA WellHotel® for Medical Travel and Well-being Accreditation which demonstrates our commitment to the safety and well-being of our wellness and medical travel guests.”

GHA WellHotel® Accreditation offers these key highlights:

  • Building trust, confidence and comfort for wellness tourists or medical travel guests through a third-party review and trusted GHA WellHotel® seal.
  • Attraction by guests in new niche markets to increase room bookings and length of stay.
  • Validation of the hotel’s cleanliness and safety and instilling peace of mind that proper cleaning and sanitation is a hotel priority.
  • Validation that safety protocols are in use for guests and staff.
  • Attraction for bookings through wellness travel agents and medical travel facilitators.
  • Providing assurance to medical travel and wellness guests that the hotel identifies and supports the cultural, dietary, religious, handicapped access, and other unique needs of the guests/patients.
  • Increase in guest satisfaction for wellness tourists and medical travel guests.
  • Well-being and medical travel packages provide an opportunity for organizations to increase TRevPAR.

The GHA WellHotel® application and accreditation process are completed conveniently online and include access to the accreditation handbook and online training.

According to Ms. Renée-Marie Stephano, GHA’s Interim Chief Executive Officer, “As travel continues to increase post-pandemic, there is a growing number of consumers that are choosing hotel experiences that support a healthy lifestyle – whether it be healthy eating plans, exercise routines, wellness programs and/or an appropriate environment to recover after a medical procedure or treatment. GHA WellHotel® demonstrates to these growing niche markets that the property has implemented programs and services that meet their unique needs and expectations and also complies with recognized industry-wide hotel cleaning and sanitation standards. We congratulate the Grand Richmond Hotel for achieving GHA WellHotel® Accreditation for Medical Travel and Well-being and applaud its commitment to prioritizing guest safety and the guest experience for wellness and medical travel guests.”

About GHA

Global Healthcare Accreditation® (GHA) is a dynamic and innovative accreditation body with specialized focused in medical and wellness travel, safety, and well-being. Founded in September of 2016, GHA’s initial purpose as an independent accrediting body centered on improving the patient experience for medical travelers and supporting healthcare providers in validating quality, increasing visibility, and implementing a sustainable business model for medical travel. Since then, GHA pioneers a variety of programs covering the entire spectrum of the care continuum and offers certification and accreditation for stakeholders in all aspects of health and wellbeing.

Visit: https://globalhealthcareaccreditation.com/

About Grand Richmond Hotel

The Grand Richmond Hotel is a distinctive five-star convention venue and hotel located in northern Bangkok, Thailand, just a short drive from the city center. The hotel features 774 luxury rooms and suites, 28 versatile and superbly equipped function rooms and two grand ballrooms. The property is operated by the Richmond Group, one of Thailand’s premier hoteliers and caters to discerning travelers from around the globe.

https://www.grandrichmondhotel.com/

Posted on

Sabin Receives Additional $21.8 Million From BARDA to Advance Marburg Vaccine

WASHINGTON, Sept. 14, 2022 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute today announced it is receiving an additional $21.8 million under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services. These funds advance development of a vaccine against Marburg virus disease, a virus that is related to Ebola Zaire which killed 2200 people during the last major outbreak that ended in 2020.

The Sabin Marburg vaccine is the only candidate currently slated for a Phase 2 clinical trial. Marburg is among the world’s deadliest viruses, resulting in the death of approximately half the people the virus infects. Currently, there are no approved vaccines or treatments for the disease. As recently as July this year, two people in Ghana died after being infected with Marburg virus, reinforcing the urgent need for medical therapies.

The latest tranche of funds enables Sabin to conduct a randomized, blinded, placebo-controlled clinical trial among adults in the U.S. to further evaluate the safety and the efficacy of the Marburg vaccine candidate and advance non-clinical vaccine dosing studies. The Phase 2 clinical trial in the U.S. will begin after Sabin has initiated a same-stage trial in Africa, currently scheduled for 2023. Sabin will also undertake a non-clinical study on the vaccine candidate during this phase.

“Beginning Phase 2 clinical trials for the Marburg vaccine is a pivotal milestone for us and we appreciate BARDA’s continued confidence in our work and support for this critical next step,” says Sabin Chief Executive Officer Amy Finan. “Vaccines remain our best bet against death and disability from deadly viruses. I am hopeful that in the years ahead, we can offer this life-saving vaccine to every person who needs it.”

In 2019, BARDA awarded Sabin a multi-year contract valued at $128 million to further the development of vaccines against two lethal viruses: Marburg and Ebola Sudan. With BARDA now exercising the latest option of that contract, Sabin’s Ebola and Marburg Research & Development program, to date, has been awarded $98.6 million.

BARDA is part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services. This project has been funded in whole or in part with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority, under contract number 75A50119C000555.

Learn more about Sabin’s Marburg and Ebola Sudan Program.

About the Sabin Vaccine Institute

The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a non-profit with more than two decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. At Sabin, we believe in the power of vaccines to change the world. For more information, visit www.sabin.org and follow us on Twitter, @SabinVaccine.

About Ebola Sudan and Marburg

Ebola Sudan and Marburg are members of the filovirus family. Both can cause severe hemorrhagic fever in humans and nonhuman primates. No therapeutic treatment of the hemorrhagic fevers caused by filoviruses has been licensed to date. Marburg and Ebola viruses are transmitted to humans by infected animals, particularly fruit bats. Once a human is infected, the virus can spread to others through close personal contact or contact with bodily fluids. Isolation of infected people is currently the centerpiece of filovirus control.

Marburg was the first filovirus to be recognized in 1967 when outbreaks of hemorrhagic fever were reported in a few Europe-based laboratories including in the town of Marburg, Germany. Ebola was identified in 1976 when two simultaneous outbreaks occurred in northern Zaire (now the DRC) in a village near the Ebola River and southern Sudan. The outbreaks involved what eventually proved to be two different species of Ebola virus; both were named after the nations in which they were discovered.

Media contact:

Rajee Suri
press@sabin.org

Posted on

JA Solar and S’ENERGY Complete Installation of 10.705MW Floating PV Project in Israel

BEIJING, Sept. 14, 2022 /PRNewswire/ — JA Solar (“the Company”), a leading manufacturer of high-performance photovoltaic (PV) products, recently announced the installation of the 10.705MW Tel Yitzhak Reservoir floating PV power plant in Israel. The project is the first to be completed as part of a 50MW order signed between JA Solar and S’energy, one of the first companies in Israel to enter the solar energy market. Ralco Energy, JA Solar partner in Israel for the last 10 years, gave full services for this project and support logistically and technically as pre&after sale service with local full package support.

JA Solar supplies modules for Tel Yitzhak Reservoir floating PV plant

The installation of floating PV power plants ensures full utilization of idle water resources to provide green electricity while reducing water evaporation and protecting water resources, which is of great importance in water-deficient areas. With its capacity of 10.705MW, the Tel Yitzhak Reservoir floating PV power plant is completely installed with JA Solar DeepBlue 3.0 PV modules. This product series has been well-received and widely recognized by global markets since its release in 2020, and its cumulative shipments had reached 24GW by the end of June 2022. In 2021, DeepBlue 3.0 became one of the first PV modules to obtain the KS high durability/eco-friendly certification in South Korea, thanks to its steady performance in high temperatures, high humidity, wet leakages, and mechanical load performance tests.

With its rich solar irradiance resources, the PV market in the Middle East and North Africa region has been developing rapidly. In the GW-scale Israeli PV market, through cooperation with leading distributors and developers including S’energy and Ralco Energy, JA Solar has gained wide recognition with its outstanding product quality and service system, proven by its  market share of around 40% in local market in 2021.

Photo – https://mma.prnewswire.com/media/1898528/JA_Solar_supplies_modules_Tel_Yitzhak_Reservoir_floating_PV_power.jpg

Posted on

Radware Launches New Cloud Security Center in the United Arab Emirates

Responds to regional demand for low latency performance and complies with offshore data routing requirements

MAHWAH, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a leading provider of cyber security and application delivery solutions, announced the launch of a new cloud security center in the United Arab Emirates. Located in Dubai, the facility will reduce latency for in-region traffic and offer customers faster mitigation response times against denial-of-service attacks, web application attacks, malicious bot traffic, and attacks on APIs. It will also mitigate compliance processes involved in offshore routing.

The Dubai addition complements Radware’s existing cloud security network. Today, the network includes over 10Tbps of mitigation capacity across more than 50 security centers located around the globe.

“As part of our strategic cloud services initiative, we continue to accelerate cloud innovation to provide our customers with the highest level of cyber security services,” said Haim Zelikovsky, vice president of cloud security services for Radware. “This includes increasing the fighting capacity of our cloud infrastructure to help our customers manage the increasing complexity and sheer volume of cyberattacks with as little disruption as possible.”

According to Radware’s First Half 2022 Global Threat Analysis Report, the first six months of 2022 saw a dramatic increase in cyberattacks across the globe. The number of DDoS attacks climbed 203% and malicious web application transactions grew by 38% compared to the same period last year.

“The new site in Dubai fills a growing demand for a local security presence that can deliver rapid response times with accuracy for organizations in the public and private sector,” said Nikhil Karan Taneja, Radware’s vice president and managing director for India, the Middle East, and South Asia. “The launch of the center underscores our ongoing commitment to delivering state-of-the-art cyber protection and scaling our capacity in a way that will benefit the whole region.”

About Radware
Radware® (NASDAQ: RDWR) is a global leader of cyber security and application delivery solutions for physical, cloud, and software defined data centers. Its award-winning solutions portfolio secures the digital experience by providing infrastructure, application, and corporate IT protection, and availability services to enterprises globally. Radware’s solutions empower enterprise and carrier customers worldwide to adapt to market challenges quickly, maintain business continuity, and achieve maximum productivity while keeping costs down. For more information, please visit the Radware website.

Radware encourages you to join our community and follow us on: Facebook, LinkedIn, Radware Blog, Twitter, YouTube, and Radware Mobile for iOS and Android.

©2022 Radware Ltd. All rights reserved. Any Radware products and solutions mentioned in this press release are protected by trademarks, patents, and pending patent applications of Radware in the U.S. and other countries. For more details, please see: https://www.radware.com/LegalNotice/. All other trademarks and names are property of their respective owners.

Radware believes the information in this document is accurate in all material respects as of its publication date. However, the information is provided without any express, statutory, or implied warranties and is subject to change without notice.

The contents of any website or hyperlinks mentioned in this press release are for informational purposes and the contents thereof are not part of this press release.

Safe Harbor Statement
This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements made herein that are not statements of historical fact, including statements about Radware’s plans, outlook, beliefs, or opinions, are forward-looking statements. Generally, forward-looking statements may be identified by words such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plans,” and similar expressions or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could.” For example, when we say that we have an ongoing commitment to scale our capacity, we are using a forward-looking statement. Because such statements deal with future events, they are subject to various risks and uncertainties, and actual results, expressed or implied by such forward-looking statements, could differ materially from Radware’s current forecasts and estimates. Factors that could cause or contribute to such differences include, but are not limited to: the impact of global economic conditions and volatility of the market for our products; natural disasters and public health crises, such as the coronavirus disease 2019 (COVID-19) pandemic; a shortage of components or manufacturing capacity could cause a delay in our ability to fulfill orders or increase our manufacturing costs; our business may be affected by sanctions, export controls, and similar measures, targeting Russia and other countries and territories, as well as other responses to Russia’s military conflict in Ukraine, including indefinite suspension of operations in Russia and dealings with Russian entities by many multi-national businesses across a variety of industries; our ability to successfully implement our strategic initiative to accelerate our cloud business; our ability to expand our operations effectively; timely availability and customer acceptance of our new and existing solutions; risks and uncertainties relating to acquisitions or other investments; the impact of economic and political uncertainties and weaknesses in various regions of the world, including the commencement or escalation of hostilities or acts of terrorism; intense competition in the market for cyber security and application delivery solutions and in our industry in general, and changes in the competitive landscape; changes in government regulation; outages, interruptions, or delays in hosting services or our internal network system; compliance with open source and third-party licenses; the risk that our intangible assets or goodwill may become impaired; our dependence on independent distributors to sell our products; long sales cycles for our solutions; changes in foreign currency exchange rates; undetected defects or errors in our products or a failure of our products to protect against malicious attacks; the availability of components and manufacturing capacity; the ability of vendors to provide our hardware platforms and components for our main accessories; our ability to protect our proprietary technology; intellectual property infringement claims made by third parties; changes in tax laws; our ability to realize our investment objectives for our cash and liquid investments; our ability to attract, train, and retain highly qualified personnel; and other factors and risks over which we may have little or no control. This list is intended to identify only certain of the principal factors that could cause actual results to differ. For a more detailed description of the risks and uncertainties affecting Radware, refer to Radware’s Annual Report on Form 20-F, filed with the Securities and Exchange Commission (SEC), and the other risk factors discussed from time to time by Radware in reports filed with, or furnished to, the SEC. Forward-looking statements speak only as of the date on which they are made and, except as required by applicable law, Radware undertakes no commitment to revise or update any forward-looking statement in order to reflect events or circumstances after the date any such statement is made. Radware’s public filings are available from the SEC’s website at www.sec.gov or may be obtained on Radware’s website at www.radware.com.

Media Contact:
Gerri Dyrek
Radware
Gerri.Dyrek@radware.com

Posted on

دراسة تؤكد عدم جاهزية نظم الصحة العالمية لمواجهة وباء آخر

اتفق 49% من العاملين في مجال الرعاية الصحية في استطلاع أجري بتكليفٍ من “ويش” على أن النظم الصحية ليست مستعدّة لإدارة حالة طوارئ صحية أخرى

الدوحة، قطر, 14 سبتمبر / أيلول 2022/PRNewswire/ — كشف استطلاع عالمي لتقييم آثار جائحة كوفيد-19على العاملين في مجال الصحة والرعاية أن الضغوط الحالية المتأتية من ضعف التمويل، ونقص الموظفين، والاستعدادات غير الملائمة تشير إلى عدم أهلية النظم الصحية في جميع أنحاء العالم للتعامل مع جائحة أخرى.

WISH and Qatar Foundation Logo

واتفق 49 % من المتخصصين في الرعاية الصحية، الذين شملهم الاستطلاع في دولٍ مثل المملكة المتحدة والولايات المتحدة الأمريكية والمملكة العربية السعودية ونيجيريا والهند والبرازيل، على أن غياب الاستعداد هو أحد أكبر التهديدات التي تواجه أنظمة بلدانهم الصحية في حال ظهرت جائحة أخرى بنفس خطورة وباء كوفيد-19 خلال السنوات الخمسة القادمة.

أجرت يوجوف ( YouGov) الاستطلاع بتكليفٍ من مؤتمر القمة العالمي للابتكار في الرعاية الصحية (ويش)، مبادرة الصحة العالمية التابعة لمؤسسة قطر .

وبحثت الدراسة مدى تأثير جائحة كوفيد-19على حياة العاملين في مجال الصحة والرعاية. كما حاولت فهم مشاعر العاملين في مجال الرعاية الصحية تجاه حياتهم المهنية ومكان عملهم، وكذلك استكشاف ما يحمله مستقبل الرعاية الصحية من وجهة نظرهم.

ومن بين العوامل التي قد تجعل النظم الصحية العالمية عرضة للفشل في حال حدوث جائحة جديدة، أشار 60 % من المتخصصين في الرعاية الصحية إلى تدني الدعم المالي، فيما شدد 55 % من المستطلعين على أن نقص المواهب يعتبر أحد العوامل الرئيسية الخطيرة على كفاءة النظم الصحية.

بالإضافة إلى ذلك، ذكر 44 % من المستطلعين أن عدم القدرة على دعم المرضى بشكل صحيح، تشكّل أيضًا تهديدًا خطيرًا على أنظمة بلدانهم الصحية.

وعلّقت سلطانة أفضل، الرئيس التنفيذي لـ”ويش”، قائلة: “تسلّط نتائج الدراسة الضوء على بعض التحديات الحرجة التي فرضتها علينا جائحة كوفيد-19 على مدار العامين الماضيين، والتي لا يزال أولئك الذين يقدمون الرعاية لنا يحاولون التخفيف منها حتى اليوم. بصفتنا مناصرين لعالم يتمتع بصحة أفضل من خلال التعاون العالمي، فإننا نحث الحكومات، وقادة القطاع، وواضعي السياسات على أخذ هذه الأفكار والعمل على بناء أنظمة صحية من الجيل التالي تكون جاهزة بشكل أفضل لمواجهة تحديات مماثلة في المستقبل، من أجل تحسين معايير الرعاية، والأهم من ذلك، تخفيف العبء الذي تشعر به القوى العاملة في مجال الرعاية الصحية لدينا”.

وأوضحت سلطانة أفضل: “لقد أدى الوباء الحالي إلى إجهاد النظم الصحية في سعيها لإيجاد تدابير استجابة عاجلة مثل زيادة قدرة قطاع الصحة، وتعزيز مكافحة العدوى، والانتقال إلى نماذج الرعاية عن بعد، وتمكين توزيع اللقاحات على الجميع، وغيرها. هناك حاجة لتقييم التحديات، ولإقبال الجهات المعنية على تمكين الاستجابة على المستوى الوطني، وكذلك توفير فرص تسريع تبادل الاستراتيجيات على الصعيد الدولي.

ويش هي منصة عالمية تجمع خبراء الرعاية الصحية وواضعي السياسات والمبتكرين معًا لتوحيد جهودهم بهدف بناء عالم يتمتع بصحة أفضل. ويتمثل هدف “قمة ويش”، التي تُقام كل سنتين، إلى عرض أبحاث “ويش” القائمة على الأدلة، ومناقشة السبل الكفيلة بترجمة نتائجها إلى حلولٍ عمليّة قائمة على السياسات تساعد في تعزيز خدمات الرعاية الصحية في جميع أنحاء العالم.

ومن المقرر أن تنعقد الدورة السادسة للقمة هذا العام بشكلٍ يجمع بين الحضور الفعلي والافتراضي في الفترة من 4 إلى 6 أكتوبر تحت شعار “نحو مستقبل مفعم بالحياة”. ستستكشف القمة بعمق إرث كوفيد-19 من وجهات نظر مختلفة، بما في ذلك كيفية بناء أنظمة رعاية صحية أكثر مرونة واستدامة، وتحسين استجابتنا لأزمة الصحة النفسية التي يواجهها العاملون في مجال الصحة والرعاية، وتسخير التقدم السريع في الابتكار الصيدلاني الذي حدث أثناء الجائحة.

لمزيد من المعلومات حول “ويش”، تفضّل بزيارة www.wish.org.qa .

الشعار – https://mma.prnewswire.com/media/1897503/WISH_QF_Logo.jpg

Posted on

Singapore’s largest HRTech Marketplace expands to the Middle East

Unveils Middle East’s HRTech Marketplace; showcases 30+ product providers servicing the Middle East geography.

DUBAI, UAE, Sept. 14, 2022 /PRNewswire/ — Singapore’s largest HR Technology Marketplace, hrtech.sg expands operations in the Middle East as hrtech.me. As part of its global expansion, the newly unveiled Middle East-focused HRTech Marketplace hosts best-in-class technology solutions to help enterprises of all sizes solve their talent challenges. The Singapore-headquartered company has been evangelizing the adoption of technology in the critical HR function since its inception in 2018 and brings the same wealth of experience to the Middle East.

hrtech. me‘s curated Marketplace currently features over 20 best-in-class HRTech product providers servicing the Middle East market. A key highlight of the platform is the unique HRTech MarketMap that helps enterprise HR teams to easily identify the best-fit solution specific to their organizational needs.

The hrtech.me Marketplace features global product players such as CoachHub (digital coaching), Darwinbox, PeopleStrong (human resources management systems), Deel (global employment platforms), Talview (video interview and assessment platform), and xoxoday (rewards and loyalty platform).

To make it simpler for the HR teams, all the solution providers are segregated into eight categories on the Marketplace, namely, Talent Acquisition, Talent Analytics, Talent Development, Talent Engagement, Talent Operations, Talent Planning, Total Rewards, and Human Resource Management Systems (HRMS). There is also a dedicated page for every product with comprehensive information about the solution. The Marketplace allows users to rate and review the products so that prospective customers make informed buying decisions.

The HRTech segment has seen strong growth in recent times as organizations seek technology solutions to effectively attract, hire, and engage talent. According to hrtech.sg‘s research, the global investments into HRTech startups stood at US$14.5 B in 2021 and over US$10.5B already in 2022 (as of Aug).

“HR has taken the front seat in the journey to navigate enterprises from the uncertainty created by the pandemic to adapting to new ways of collaborative work. Technology is the power that fuels the HR engine to create a unique employee experience and engagement, while at the same time allowing for new ways of collaboration and communication among diverse, dispersed teams across the globe. We are focused on empowering organizations with their digital HR roadmap to create a great employee experience,” says Sriram Iyer, Founder & CEO, hrtech.sg.

About hrtech.sg

hrtech.sg is Singapore-headquartered HR Technology-focused market development & analyst firm, that is focused on creating the greatest possible value for enterprise clients by matching the right HRTech solutions to address talent challenges for delivering strong business outcomes. The firm focuses on creating a tech-driven, data-centric HR ecosystem that will help drive successful Workplace & Talent Transformation.

For more information, please contact

Sriram Iyer (Founder & CEO, +6590251164, sriram@hrtech.sg)
Swechha Mohapatra (Head – Research & Consulting, swechha@hrtech.sg)
Sanika Sarmalkar (Market Lead – Middle East, sanika@hrtech.me).